Zydus Cadila

NSE:ZYDUSLIFE

Ahmedabad, India· Est. 1952

A global, fully integrated pharmaceutical company developing and manufacturing generic medicines, small molecules, biologics, and vaccines across multiple therapeutic areas.

zydususa.com

Is this your company? Claim your profile to update info and connect with investors.

Claim profile

AI Company Overview

A global, fully integrated pharmaceutical company developing and manufacturing generic medicines, small molecules, biologics, and vaccines across multiple therapeutic areas.

OncologyCardiovascularInfectious DiseaseDermatologyNeurologyImmunology

Technology Platform

Integrated pharmaceutical development platform spanning small molecules, novel drug delivery systems including nanotechnology, biologics, and vaccine development capabilities.

Opportunities

Growth opportunities include expanding generic portfolio in the US market, leveraging vaccine development capabilities for emerging infectious diseases, and advancing innovative research programs from their discovery pipeline.

Risk Factors

Key risks include intense competition and pricing pressure in generic markets, regulatory compliance challenges across global operations, and dependence on successful commercialization of innovative products to drive long-term growth.

Competitive Landscape

Competes with other large generic pharmaceutical companies like Sun Pharma, Dr. Reddy's, and Teva, while differentiating through fully integrated operations, specialized manufacturing capabilities in complex generics, and a growing focus on innovative research and vaccine development.

More companies in India →